Skip to main content
Figure 2 | Journal of Translational Medicine

Figure 2

From: Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors

Figure 2

ABCC1 expression in MPNST-derived cell line NF02. A) Quantitative real-time PCR confirms elevated expression in NF02.2 compared to benign neurofibroma-derived cell lines MS37T, MS80T, and MS90T. B) Immunofluorescent staining for ABCC1 (green) and S100 (red) with DAPI (blue) nuclear stain as indicated. No primary antibodies were added in (C). Scale bar = 10 μm.

Back to article page